Reducing Use of Sleep Medications Assisted by a Digital Insomnia Intervention
Key facts
- Who runs it
- VA Office of Research and Development
- Where
- Pittsburgh, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 36 people enrolled
- Started
- 22 Sept 2022
- Ended
- 30 Jun 2024
- Type of study
- Interventional
- Treatments tested
- Cognitive Behavioral Therapy for Insomnia
- Deprescribing
- Record updated
- 11 April 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (8)Hide the full registry criteria
Who can take part
- A Veteran receiving care at VA Pittsburgh Healthcare System
- Active sedative-hypnotic medication use >14 days/month for >=3 months
- A desire to reduce or stop using sedative-hypnotic medications
- Access to a mobile device with internet
Who cannot take part
- A disorder that would impair participation (e.g., cancer, uncontrolled pain, severe depression)
- A disorder that can be exacerbated by changes in sleep (e.g., seizure disorder, bipolar I disorder)
- An active substance use disorder in past 6 months
- High risk of suicide
Where in United States
- VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PAPittsburgh, United States
About the trial
What the trial wants to find out
Chronic insomnia is one of the most common health problems among Veterans and significantly impacts their health, function, and quality of life. Sedative-hypnotic medications are the most common treatment despite mixed effectiveness and are associated with numerous risks that can further impact Veteran function. An intervention combining evidence-based interventions for deprescribing sedative-hypnotics and behavioral interventions for insomnia (e.g., Cognitive Behavioral Therapy for Insomnia [CBT-I]) can help to optimize sleep and functional outcomes for Veterans with a desire to reduce or stop using these medications. Furthermore, by delivering these interventions through an easy to use and highly accessible digital platform can provide additional benefits to Veterans, especially those with limited time and access to engage in traditional in-person interventions. The Clinician Operated Assistive Sleep Technology (COAST) is an efficient, scalable, and adaptable platform that can help providers to reach more Veterans and provide evidence-based care that translates to improved health and function.
Read full original descriptionShow less
Aim 1: To assess the feasibility of recruiting Veterans with chronic sedative-hypnotic use to participate in a 12-week combined deprescribing and CBT-I intervention, delivered through the COAST digital platform.
Aim 2: To assess Veteran acceptability and usability of the COAST platform.
Aim 3: To assess change in Veteran sleep, sedative-hypnotic use, and function pre- to post-intervention.
The group in the trial
- COAST + DeprescribingTreatment being tested
CBT-I with simultaneous sedative-hypnotic deprescribing delivered through a digital platform
Treatment: Cognitive Behavioral Therapy for Insomnia and Deprescribing
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- SEdative-Hypnotic Deprescribing Assisted by a Technology-Driven Insomnia InterVEntion (SEDATIVE)
- Publications
- Record updated
- 11 April 2025